Increased Mobilization of Mesenchymal Stem Cells in Patients With Essential Hypertension: The Effect of Left Ventricular Hypertrophy

Journal of Clinical Hypertension

Volumn 16, Issue 12, 2014, Pages 883-888

  Marketou, Maria E ^a   Parthenakis, Fragiskos I ^a   Kalyva, Athanasia ^b   Pontikoglou, Charalampos ^a   Maragkoudakis, Spyros ^a   Kontaraki, Joanna E ^b   Zacharis, Evangelos A ^a   Chlouverakis, Gregory ^b   Patrianakos, Alexandros ^a   Papadaki, Helen A ^a   Vardas, Panos E ^a  

^a UNIVERSITY HOSPITAL OF HERAKLION   (Greece)

^b UNIVERSITY OF CRETE   (Greece)

Author keywords

[No Author keywords available]

Indexed keywords

CD34 ANTIGEN; CD45 ANTIGEN; ENDOGLIN; THY 1 ANTIGEN;

ADULT; ARTICLE; BLOOD SAMPLING; CELL COUNT; CELL POPULATION; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; FEMALE; FLOW CYTOMETRY; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; MALE; MESENCHYMAL STEM CELL; PRIORITY JOURNAL; PROSPECTIVE STUDY; STEM CELL MOBILIZATION; TWO DIMENSIONAL ECHOCARDIOGRAPHY; AGED; BLOOD; CYTOLOGY; ECHOCARDIOGRAPHY; HYPERTENSION; MESENCHYMAL STROMA CELL; MIDDLE AGED; PATHOPHYSIOLOGY;

AGED; ECHOCARDIOGRAPHY; FEMALE; FLOW CYTOMETRY; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; MALE; MESENCHYMAL STROMAL CELLS; MIDDLE AGED; PROSPECTIVE STUDIES;

EID: 84919653102     PISSN: 15246175     EISSN: 17517176     Source Type: Journal    
DOI: 10.1111/jch.12426     Document Type: Article

References (35)

1. Mollova M, Bersell K, Walsh S, et al. Cardiomyocyte proliferation contributes to heart growth in young humans. Proc Natl Acad Sci USA. 2013;110:1446-1451.
2. Bergmann O, Bhardwaj RD, Bernard S, et al. Evidence for cardiomyocyte renewal in humans. Science. 2009;324:98-102.
3. Gojo S, Gojo N, Takeda Y, et al. In vivo cardiovasculogenesis by direct injection of isolated adult mesenchymal stem cells. Exp Cell Res. 2003;288:51-59.
4. Kobayashi T, Hamano K, Li TS, et al. Enhancement of angiogenesis by the implantation of self bone marrow cells in a rat ischemic heart model. J Surg Res. 2000;89:189-195.
5. Tomita S, Li RK, Weisel RD, et al. Autologous transplantation of bone marrow cells improves damaged heart function. Circulation. 1999;100:II247-II256.
6. Sato T, Iso Y, Uyama T, et al. Coronary vein infusion of multipotent stromal cells from bone marrow preserves cardiac function in swine ischemic cardiomyopathy via enhanced neovascularization. Lab Invest. 2011;91:553-564.
7. Tondreau T, Meuleman N, Delforge A. Mesenchymal stem cells derived from CD133-positive cells in mobilized peripheral blood and cord blood: proliferation, Oct4 expression, and plasticity. Stem Cells. 2005;23:1105-1112.
8. Noort WA, Oerlemans MI, Rozemuller H, et al. Human versus porcine mesenchymal stromal cells: phenotype, differentiation potential, immunomodulation and cardiac improvement after transplantation. J Cell Mol Med. 2012;16:1827-1839.
9. Anversa P, Kajstura J, Rota M, et al. Regenerating new heart with stem cells. J Clin Invest. 2013;123:62-70.
10. Müller P, Kazakov A, Semenov A, et al. Pressure-induced cardiac overload induces upregulation of endothelial and myocardial progenitor cells. Cardiovasc Res. 2008;77:151-159.
11. Sopko NA, Turturice BA, Becker ME, et al. Bone marrow support of the heart in pressure overload is lost with aging. PLoS One. 2010;5:e15187.
12. Kontaraki JE, Marketou ME, Zacharis EA, et al. Early cardiac gene transcript levels in peripheral blood mononuclear cells in patients with untreated essential hypertension. J Hypertens. 2011;29:791-797.
13. Yamada T, Kondo T, Numaguchi Y, et al. Angiotensin II receptor blocker inhibits neointimal hyperplasia through regulation of smooth muscle-like progenitor cells. Arterioscler Thromb Vasc Biol. 2007;27:2363-2369.
14. Mancia G, de Backer G, Dominiczak A, et al. Guidelines for the Management of Arterial Hypertension. The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2007;25:1751-1762.
15. Lang RM, Bierig M, Devereux RB, et al. Recommendations for chamber quantification. Eur J Echocardiogr. 2006;7:79-108.
16. Schiller N, Shah P, Crawford M, et al. Recommendations for quantitation of the left ventricle by two-dimensional echocardiography. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms. J Am Soc Echocardiogr. 1989;2:358-367.
17. Devereux R, Reichek N. Echocardiographic determination of left ventricular mass in man: anatomic validation of the method. Circulation. 1977;55:613-618.
18. Marketou ME, Vardas PE. Stem cells and hypertension: another challenge for the future? Hellenic J Cardiol. 2011;52:289-292.
19. Torella D, Ellison GM, Méndez-Ferrer S, et al. Resident human cardiac stem cells: role in cardiac cellular homeostasis and potential for myocardial regeneration. Nat Clin Pract Cardiovasc Med. 2006;3:S8-S13.
20. Koudstaal S, Jansen O, Lorkeers SJ, et al. Concise review: heart regeneration and the role of cardiac stem cells. Stem Cells Transl Med. 2013;2:434-443.
21. van Oostrom O, Fledderus JO, de Kleijn D, et al. Smooth muscle progenitor cells: friend or foe in vascular disease? Curr Stem Cell Res Ther. 2009;4:131-140.
22. Pittenger MF, Martin BJ. Mesenchymal stem cells and their potential as cardiac therapeutics. Circ Res. 2004;95:9-20.
23. Kucia M, Ratajczak J, Ratajczak MZ. Bone marrow as a source of circulating CXCR4 + tissue-committed stem cells. Biol Cell. 2005;97:133-146.
24. Wojakowski W, Tendera M, Michalowska A, et al. Mobilization of CD34 + /CXCR4 + , CD34-/CD117 + , c-met+ stem cells, and mononuclear cells expressing early cardiac muscle, and endothelial markers into peripheral blood in patients with acute myocardial infarction. Circulation. 2004;110:3213-3220.
25. Mouquet F, Pfister O, Jain M, et al. Restoration of cardiac progenitor cells after myocardial infarction by self-proliferation and selective homing of bone marrow-derived stem cells. Circ Res. 2005;97:1090-1092.
26. Li TS, Suzuki R, Ueda K, et al. Analysis of the origin and population dynamics of cardiac progenitor cells in a donor heart model. Stem Cells. 2007;25:911-917.
27. Messina E, De Angelis L, Frati G, et al. Isolation and expansion of adult cardiac stem cells from human and murine heart. Circ Res. 2004;95:911-921.
28. Pfister O, Mouquet F, Jain M, et al. CD31- but not CD31+ cardiac side population cells exhibit functional cardiomyogenic differentiation. Circ Res. 2005;97:52-61.
29. Makino S, Fukuda K, Miyoshi S, et al. Cardiomyocytes can be generated from marrow stromal cells in vitro. J Clin Invest. 1999;103:697-705.
30. Jiang Y, Jahagirdar BN, Reinhardt RL, et al. Pluripotency of mesenchymal stem cells derived from adult marrow. Nature. 2002;418:41-49.
31. Orlic D, Kajstura J, Chimenti S, et al. Bone marrow cells regenerate infarcted myocardium. Nature. 2001;410:701-705.
32. Kontaraki JE, Parthenakis FI, Patrianakos AP, et al. Altered expression of early cardiac marker genes in circulating cells of patients with hypertrophic cardiomyopathy. Cardiovasc Pathol. 2007;16:329-350.
33. Iso Y, Yamaya S, Sato T, et al. Distinct mobilization of circulating CD271+ mesenchymal progenitors from hematopoietic progenitors during aging and after myocardial infarction. Stem Cells Transl Med. 2012;1:462-468.
34. Verdecchia P, Carini G, Circo A, et al; MAVI (MAssa Ventricolare sinistra nell'Ipertensione) Study Group. Left ventricular mass and cardiovascular morbidity in essential hypertension: the MAVI study. J Am Coll Cardiol. 2001;38:1829-1835.
35. Castellani C, Padalino M, China P, et al. Bone-marrow-derived CXCR4-positive tissue-committed stem cell recruitment in human right ventricular remodeling. Hum Pathol. 2010;41:1566-1576.